Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study.

A, Murphy; B, Palafox; O, O'Donnell; D, Stuckler; P, Perel; KF, AlHabib; A, Avezum; X, Bai; J, Chifamba; CK, Chow; DJ, Corsi; GR, Dagenais; AL, Dans; R, Diaz; AN, Erbakan; N, Ismail; R, Iqbal; R, Kelishadi; R, Khatib; F, Lanas; SA, Lear; W, Li; J, Liu; P, Lopez-Jaramillo; V, Mohan; N, Monsef; PK, Mony; T, Puoane; S, Rangarajan; A, Rosengren; AE, Schutte; M, Sintaha; KK, Teo; A, Wielgosz; K, Yeates; L, Yin; K, Yusoff; K, Zatońska; S, Yusuf; M, McKee

doi:10.1016/s2214-109x(18)30031-7

Public

Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study.

Shared by NobleBlocks on Mar 1, 2018 • 12:00 AM UTC

Authors:

Murphy A

Palafox B

O'Donnell O

Abstract

Background There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development.Methods We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals wit...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!